Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Journal of Cancer Survivorship : Research and Practice|March 26, 2026
Dietary intervention among young cancer survivors within the CARE for CAYA programJulia von Grundherr, Simon Elmers, Luisa Samland, et al.
Journal of Clinical Immunology|September 19, 2022
Long-Term Antibody Response to SARS-CoV-2 in ChildrenGabor A Dunay, Madalena Barroso, Mathias Woidy, et al.
Blood|November 14, 2013
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study groupTrudy D Buitenkamp, Shai Izraeli, Martin Zimmermann, et al.
Neuro-Oncology|May 13, 2017
Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPNJohn-Paul Kilday, Massimo Caldarelli, Luca Massimi, et al.
The EMBO Journal|May 30, 2024
IL-27 maintains cytotoxic Ly6C+ γδ T cells that arise from immature precursorsRobert Wiesheu, Sarah C Edwards, Ann Hedley, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2020
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatmentOndrej Hrusak, Tomas Kalina, Joshua Wolf, et al.
Blood|November 4, 2022
EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapySarah Elitzur, Ajay Vora, Birgit Burkhardt, et al.
Blood|June 25, 2024
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignanciesSarah Elitzur, Ruth Shiloh, Jan L C Loeffen, et al.
The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very youngShunsuke Kimura, Petri Polonen, Lindsey Montefiori, et al.
Pageof 18